REQUEST A DEMO
Total
USD $0.00
Search more companies

Cure Latam Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Cure Latam Sas Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cure Latam Sas is a company in Colombia, with a head office in Barranquilla. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on January 30, 2020. There are currently 17 (2023) people employed by Cure Latam Sas. From the latest financial highlights, Cure Latam Sas reported a net sales revenue increase of 273.46% in 2023. There was a total growth of 118.17% in Cure Latam Sas’s total assets over the same period. In, 2023, the company’s net profit margin decreased by 23.59%.

Headquarters
Cr 61 Cl 75 91 Lc 1
Barranquilla; Atlantico;

Contact Details: Purchase the Cure Latam Sas report to view the information.

Basic Information
Total Employees:
Purchase the Cure Latam Sas report to view the information.
Outstanding Shares:
Purchase the Cure Latam Sas report to view the information.
Incorporation Date:
January 30, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Cure Latam Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
273.46%
Total operating revenue
273.46%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
1.17%
Total assets
118.17%
Total equity
137.41%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-23.59%
Return on Equity (ROE)
-28.91%
Debt to Equity Ratio
-17.2%
Quick Ratio
-0.09%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?